ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 135 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 2.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $126,000 | -6.0% | 11,002 | +0.6% | 0.00% | – |
| Q3 2017 | $134,000 | +3.1% | 10,936 | -3.6% | 0.00% | – |
| Q2 2017 | $130,000 | -65.6% | 11,342 | -37.6% | 0.00% | -100.0% |
| Q1 2017 | $378,000 | +6.2% | 18,189 | +6.3% | 0.00% | 0.0% |
| Q4 2016 | $356,000 | -36.4% | 17,113 | +0.1% | 0.00% | -50.0% |
| Q3 2016 | $560,000 | +54.3% | 17,088 | +17.7% | 0.00% | +100.0% |
| Q2 2016 | $363,000 | +28.3% | 14,520 | +25.6% | 0.00% | 0.0% |
| Q1 2016 | $283,000 | -27.4% | 11,564 | -2.0% | 0.00% | 0.0% |
| Q4 2015 | $390,000 | +4.3% | 11,801 | +3.5% | 0.00% | -50.0% |
| Q3 2015 | $374,000 | – | 11,403 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,130 | $34,629,000 | 11.36% |
| Foresite Capital Management II, LLC | 1,586,220 | $18,670,000 | 10.50% |
| DAFNA Capital Management LLC | 636,013 | $7,486,000 | 2.81% |
| Redmile Group, LLC | 8,244,896 | $97,042,000 | 2.75% |
| Lion Point Capital, LP | 1,204,600 | $14,178,000 | 1.40% |
| Palo Alto Investors LP | 1,861,630 | $21,911,000 | 1.06% |
| SAMLYN CAPITAL, LLC | 3,517,856 | $41,405,000 | 0.87% |
| Bellevue Group AG | 4,118,806 | $48,478,000 | 0.83% |
| Rock Springs Capital Management LP | 1,562,300 | $18,388,000 | 0.66% |
| Artal Group S.A. | 850,000 | $10,005,000 | 0.40% |